MMR vaccine

The MMR vaccine is an immunization vaccine against measles, mumps, and rubella (German measles).

MMR vaccine

NA

Morupar, Priorix, Tresivac, Trimovax, Trimovax Merieux

NA

NA

NA

NA

NA

Injection-site reactions such as pain and induration. Fever, rash, measles-like rash.

• Concurrent use with immunosuppressants may increase the adverse effects of vaccines; may also reduce the efficacy of vaccines.
• Immune globulins may reduce the efficacy of vaccines. May reduce the diagnostic effect of tuberculin tests.

• Current febrile respiratory illness or other febrile infection.
• Patients receiving immunosuppressive therapy; primary and acquired immunodeficiency states.
• Blood dyscrasias, cancers affecting the bone marrow or lymphatic systems.
• Pregnancy.
• Active untreated tuberculosis.

Store at 2-8°C. 

Molecular weight

NA

Molecular formula

NA

CAS number

NA

Precautions

• Patients with history of cerebral injury or seizures.
• Patients with thrombocytopenia and those who develop thrombocytopenia after 1st dose.
• For patients with active tuberculosis, tuberculosis treatment should be started before using the vaccine.
• Vaccination may be deferred in patients with moderate or severe acute illness.
• Pregnancy should be avoided for 28 days after vaccination.
• Lactation.